Enfortumab vedotin induced interstitial lung disease: A first case report with pathological evidence from transbronchial lung cryobiopsy

Enfortumab vedotin (EV), an antibody–drug conjugate targeting Nectin-4, has demonstrated efficacy against advanced urothelial carcinoma. While initially considered rare, EV-induced interstitial lung disease (ILD) is increasingly recognized, yet its pathological features remain poorly characterized....

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Shota Kaburaki, Toru Tanaka, Koichiro Kamio, Yosuke Tanaka, Kazuo Kasahara, Yasuhiro Terasaki, Masahiro Seike
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Elsevier 2025-01-01
סדרה:	Respiratory Medicine Case Reports
נושאים:	Enfortumab vedotin Interstitial lung disease Antibody–drug conjugate Nectin-4 Transbronchial cryobiopsy Non-specific interstitial pneumonia
גישה מקוונת:	http://www.sciencedirect.com/science/article/pii/S2213007125000735
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!